🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07141173
Starting soon Not applicable

Effect of Early Lifestyle Intervention on Perinatal Outcomes in High-risk Women for Gestational Hyperglycemia

NCT07141173 · tracked via the Priya Life Science China tracker
Sponsor
Tianjin Central Hospital of Gynecology Obstetrics
Phase
Not applicable
Started
2025-08-20
Last updated
2025-08-26

Condition(s) studied

GDM

Investigational drug(s) / intervention(s)

Individual lifestyle management

Individual lifestyle management: Manage the diet, exercise, weight and healthy lifestyle of pregnant women

Study summary

This study aims to explore whether early intervention for high-risk groups of gestational hyperglycemia can improve insulin resistance and effectively prevent the occurrence of GDM, and evaluate which pathophysiological subtypes of GDM have the best effect on improving maternal and fetal adverse prognosis, so as to provide evidence for stratified management and individualized clinical intervention of high glucose groups in pregnancy

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: * 18-55 years old * 6-14 weeks of pregnancy * at least one risk factor for GDM * signed a written informed consent Exclusion Criteria: * Individuals diagnosed with diabetes or prediabetes prior to pregnancy * currently taking medications affecting blood glucose levels such as metformin * women at risk of miscarriage * individuals with chronic conditions (such as uncontrolled hypertension, severe heart disease) * those with movement disorders or contraindicated conditions for physical activity * patients undergoing gastrointestinal surgeries that alter glucose absorption * those unable to maintain regular prenatal care (such as non-compliance with medical instructions or mental health issues).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tianjin Central Hospital of Gynecology Obstetrics Tianjin China

More Tianjin Central Hospital of Gynecology Obstetrics trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07141173 on ClinicalTrials.gov ↗ ← All trials in China